Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-2 and Bone Resorption in Postmenopausal Women with Osteopenia
2005-003076-37Phase 2Completed
- Sponsor
- Sanos Group
- Start
- Jul 2005
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of glucagon-like peptide-2 in osteopenia (4 arms), sponsored by Sanos Group. Primary endpoint: Change in serum C-terminal telopeptide of type I collagen (s-CTX). Started Jul 2005; status: completed.
02
Drugs
glucagon-like peptide-2
03
Conditions
osteopenia
Beyond the preview
Go deeper on 2005-003076-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003076-37.